Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:02 PM ET 10-Q
Financial Results Niagen Bioscience, Inc. NAGE ▶ Call

Niagen Bioscience Q3 2026 Results: Net Loss of $1.17M

Niagen Bioscience reported a net loss of $1.2 million for the third quarter of 2026, a significant decline from a $4.6 million profit in the prior year, driven by a 20% decrease in net sales. However, for the nine-month period, the company remained profitable with a net income of $6.1 million, bolstered by a $4.8 million gain from the sale of an operating segment.

Key figure
Net loss $1.17M
4:02 PM ET 8-K
Financial Results Arko Petroleum Corp. APC

Arko Petroleum Financial Results

ARKO Petroleum Corp. reported third quarter 2026 net income of $13.3 million and Adjusted EBITDA of $41.0 million, representing year-over-year growth. The company raised its full-year 2026 Adjusted EBITDA guidance and declared a quarterly dividend of $0.50 per share.

Term
Q3 2026

“APC’s third-quarter results reinforce the strategy we outlined at the IPO. Adjusted EBITDA and Discretionary Cash Flow grew year over year, which we believe demonstrated the durability of our platform, the stability of its cash generation and our team’s ability to execute effectively through a volatile market environment. Based on year-to-date performance, our outlook for the balance of the year and the expected closing of USPP, we are raising our full-year 2026 Adjusted EBITDA guidance.”

Arie Kotler, Chairman, President and Chief Executive Officer of APC
4:02 PM ET 8-K
Financial Results Mercadolibre Inc MELI

Mercadolibre Financial Results

MercadoLibre reported third-quarter 2026 net revenues of $10.75 billion, a 45% increase year-over-year, driven by strong performance in Brazil and deepening ecosystem engagement. Net income for the period was $448 million, while income from operations decreased 6% to $676 million due to investments in free shipping, fulfillment capacity, and marketing.

Term
Q3 2026
4:02 PM ET 10-Q
Financial Results AGL Private Credit Income Fund

AGL Private Credit Income Fund Q3 2026 Results: Turns Profitable, Net Income $19M

AGL Private Credit Income Fund reported total assets of $1.54 billion as of September 30, 2026, with a portfolio primarily consisting of non-controlled, non-affiliated investments valued at $1.46 billion. The fund maintained 27,060,888 common shares outstanding and reported total debt of $861.6 million, net of deferred financing costs.

Key figure
Net income $19M
4:02 PM ET 8-K
Clinical Trial Data Moleculin Biotech, Inc. MBRX

Moleculin Biotech Clinical Trial Data

Moleculin Biotech announced that interim data from its pivotal Phase 2/3 trial (MB-108) of Annamycin for relapsed or refractory AML will be presented at the 2026 ASH Annual Meeting. The data showed complete remission rates of 43% and 36% in the treatment arms compared to 12% for placebo, with no observed cardiotoxicity. The independent Data Monitoring Committee recommended the study continue without amendment.

4:02 PM ET 8-K
Loan & Debt Microsoft Corp MSFT

Microsoft $25B Debt Financing with J.P. Morgan Securities LLC

Microsoft Corporation entered into an underwriting agreement for the issuance and sale of $25 billion in aggregate principal amount of senior notes across ten different tranches. The offering includes both floating rate and fixed rate notes with maturities ranging from 2028 to 2066, with J.P. Morgan, UBS, and Wells Fargo acting as representatives for the underwriters.

Value
$25B
Counterparty
J.P. Morgan Securities LLC
Term
through 2066
4:02 PM ET 8-K
Financial Results Allegiant Travel CO ALGT

Allegiant Travel Financial Results

Allegiant Travel Company reported third quarter 2026 financial results, including a GAAP net loss of $15.2 million and an adjusted diluted loss per share of $0.03. The results reflect the first full quarter of operations following the acquisition of Sun Country, with total operating revenue increasing 71.1% year-over-year to $961.6 million.

Term
Q3 2026

“Allegiant delivered another quarter of operating profitability, expanding our adjusted operating margin by 340 basis points year over year on a pro forma basis in our seasonally slowest quarter, despite a more than 55 percent surge in fuel costs per gallon.”

Greg Anderson, chief executive officer of Allegiant Travel Company

“With strong booking momentum, we remain confident in our 2026 full-year adjusted earnings per share guidance of greater than $6.00, despite elevated fuel costs.”

Greg Anderson, chief executive officer of Allegiant Travel Company
4:02 PM ET 8-K
Financial Results Niagen Bioscience, Inc. NAGE

Niagen Bioscience Financial Results

Niagen Bioscience reported Q3 2026 net sales of $27.2 million and a net loss of $1.2 million, while generating $2.6 million in operating cash flow. The company launched several new products including Niagen NanoCloud topical and an at-home injection kit, while expanding retail distribution through Walmart.com, GNC, and Sam's Club.

Term
Q3 2026

“During the third quarter, we navigated near-term commercial headwinds while continuing to generate positive adjusted EBITDA and $2.6 million in operating cash flow and make tangible progress across the Niagen platform. We advanced NB4168, expanded Tru Niagen distribution, established skincare as a permanent category, launched a more convenient ready-to-inject Niagen Plus product, and invested in brand awareness and long-term clinical research. As stated before, we view 2026 as an investment year, and believe the progress we are making across consumer health, ingredients, injectables, skincare, and pharmaceuticals provides a strong springboard for meaningful growth in 2027 and beyond.”

Rob Fried, Chief Executive Officer
4:02 PM ET 8-K
Clinical Trial Data ADC Therapeutics SA ADCT

ADC Therapeutics Clinical Trial Data

ADC Therapeutics announced updated clinical data for ZYNLONTA from several trials, including the LOTIS-7 Phase 1b study which showed an 88.7% overall response rate and 75.3% complete response rate in relapsed or refractory large B-cell lymphoma. The data, which will be presented at the ASH Annual Meeting, also highlighted a 93% ORR in marginal zone lymphoma and results from the Phase 3 LOTIS-5 study. These findings support the company's plans to advance ZYNLONTA into Phase 3 studies for expanded indications.

4:01 PM ET 10-Q
Financial Results Terreno Realty Corp TRNO

Terreno Realty Q3 2026 Results: Net Income $68.1M, Down 34.1% YoY

Terreno Realty Corp reported net income of $195.1 million for the nine months ended September 30, 2026, a decrease from $244.8 million in the prior year period primarily due to lower gains on real estate sales. Total revenues increased to $381.4 million from $338.9 million, while the company continued to expand its portfolio with $326.9 million in property acquisitions during the period.

Key figure
Net income $68.1M · -34.1% YoY
4:01 PM ET 8-K
Financial Results Arko Corp. ARKO

Arko Financial Results

ARKO Corp. subsidiary ARKO Petroleum Corp. reported third quarter 2026 net income of $13.3 million and Adjusted EBITDA of $41.0 million. Based on year-to-date performance and the pending acquisition of U.S. Petroleum Partners, LLC, the company raised its full-year 2026 Adjusted EBITDA guidance and declared a $0.50 per share quarterly dividend.

“APC’s third-quarter results reinforce the strategy we outlined at the IPO. Adjusted EBITDA and Discretionary Cash Flow grew year over year, which we believe demonstrated the durability of our platform, the stability of its cash generation and our team’s ability to execute effectively through a volatile market environment. Based on year-to-date performance, our outlook for the balance of the year and the expected closing of USPP, we are raising our full-year 2026 Adjusted EBITDA guidance.”

Arie Kotler, Chairman, President and Chief Executive Officer of APC
4:01 PM ET Form 4
Insider Selling Liquidity Services Inc LQDT

Liquidity Services EVP, Chief Commercial Officer John Daunt Sells $32K of Stock

John Daunt, EVP, Chief Commercial Officer, sold 715 shares of Liquidity Services Inc at $44.71 a share, worth $32K in total on Nov 2, 2026. Shares held after the trade: 38,086 (-1.0%).

Value
$32K
Shares
715
Average price
$44.71
Role
EVP, Chief Commercial Officer
Holding change
-1.0%
Trade date
Nov 2, 2026
4:01 PM ET Form 4
Insider Selling Fate Therapeutics Inc FATE

Fate Therapeutics CFO Kamal Adawi Sells $13.5K of Stock

Kamal Adawi, CFO, sold 6,582 shares of Fate Therapeutics Inc at $2.05 a share, worth $13.5K in total on Nov 3, 2026. Shares held after the trade: 93,418 (-6.6%).

Value
$13.5K
Shares
6,582
Price
$2.05
Role
CFO
Holding change
-6.6%
Trade date
Nov 3, 2026
4:01 PM ET 10-Q
Financial Results Damora Therapeutics, Inc. DMRA

Damora Therapeutics Q3 2026 Results: Net Loss of $32M, Loss Widens

Damora Therapeutics reported a significant increase in operating expenses for the nine months ended September 30, 2026, totaling $102.7 million compared to $9.2 million in the prior year, primarily driven by R&D for candidates DMR-001, DMR-002, and DMR-003. The company ended the period with $528.5 million in cash and marketable securities following a substantial increase in ordinary shares outstanding to 61.9 million.

Key figure
Net loss $32M
4:01 PM ET 8-K
Financial Results Magnolia Oil & Gas Corp MGY

Magnolia Oil & Gas Financial Results

Magnolia Oil & Gas reported Q3 2026 net income of $80.5 million and adjusted net income of $166.3 million, driven by a 17% year-over-year increase in production to 117.3 Mboe/d. The results include the partial-period impact of the WildFire Energy acquisition, which closed during the quarter. The company also increased its share repurchase authorization by 15 million shares and generated $223.7 million in adjusted free cash flow.

Term
Q3 2026

“Magnolia continues to execute at a high level as we successfully integrate the WildFire assets. Although our third quarter results include only a partial period of ownership following the September closing, the benefits of the combined asset base are already clearly evident. Our business generated $224 million of adjusted free cash flow during the quarter, with a reinvestment rate of just 38 percent of adjusted EBITDAX.”

Chris Stavros, Chairman, President and CEO
4:01 PM ET 8-K
M&A Deal Neogen Corp NEOG

Neogen M&A Deal with Zoetis Inc.

Neogen Corporation provided a status update on the pending sale of its global Genomics business to Zoetis Inc. To facilitate regulatory clearance from the ACCC and NZCC, Zoetis has offered to divest certain assets in Australia, with the transaction now expected to close in early 2027.

Counterparty
Zoetis Inc.
4:01 PM ET 8-K
Nasdaq/NYSE Compliance Notice Bayview Acquisition Corp BAYA

Bayview Acquisition Nasdaq/NYSE Compliance Notice

Bayview Acquisition Corp received notice that the Nasdaq board of directors declined to review a prior decision to delist the company's securities. Nasdaq will proceed with filing a Form 25-NSE to formally remove the company's units, ordinary shares, and rights from listing. The company is currently seeking to have its ordinary shares quoted on the OTC Pink Market.

Counterparty
Nasdaq
4:01 PM ET 8-K
Financial Results Expedia Group, Inc. EXPE

Expedia Group Financial Results

Expedia Group reported Q3 2026 financial results, exceeding guidance with 12% revenue growth and 11% gross bookings growth year-over-year. The company also increased its full-year 2026 guidance and declared a quarterly cash dividend of $0.48 per share.

Term
Q3 2026

“We exceeded the high end of our guidance in the quarter, reflecting resilient travel demand and strong execution. We continue to deliver traveler value through more personalized and rewarding product experiences, improve supply across our marketplace, and advance our strategy to build the one-stop travel platform for B2B partners.”

Ariane Gorin, CEO of Expedia Group
4:00 PM ET 8-K
Loan & Debt Mcgrath Rentcorp MGRC

Mcgrath Rentcorp $350M Debt Financing with PGIM, Inc.

McGrath RentCorp entered into an amendment to its Note Purchase and Private Shelf Agreement, increasing its revolving private shelf facility to $350 million. As part of the agreement, the company issued and sold $75 million of 6.53% Series H Senior Notes maturing in November 2031. The amendment also increased cross-default and judgment thresholds from $10 million to $20 million.

Value
$350M
Counterparty
PGIM, Inc.
Term
through Nov 2031
4:00 PM ET 8-K
Capital Raise New Mountain Net Lease Trust NEWLEASE

New Mountain Net Lease Trust Capital Raise of $31.1M

New Mountain Net Lease Trust sold 1,476,784 common shares in a continuous private offering for approximately $31.13 million. The sale included Class F and Class I common shares issued at the most recently determined net asset value per share.

Value
$31.1M
4:00 PM ET 8-K
Capital Raise Jefferies Credit Partners BDC Inc.

Jefferies Credit Partners BDC Capital Raise of $6.61M

Jefferies Credit Partners BDC Inc. sold 462,715.212 unregistered shares of its Class I common stock to third-party investors. The shares were sold at a price of $14.29202 per share, representing the company's NAV as of September 30, 2026, for total consideration of approximately $6.61 million.

Value
$6.61M
3:58 PM ET Form 4
Insider Selling Fti Consulting, Inc FCN

Fti Consulting Chief Strategy/Transf. Officer Paul Alderman Linton Sells $832K of Stock

Paul Alderman Linton, Chief Strategy/Transf. Officer, sold 4,378 shares of Fti Consulting, Inc at $190.00 a share, worth $832K in total on Nov 3, 2026. Shares held after the trade: 92,824 (-4.5%).

Value
$832K
Shares
4,378
Price
$190.00
Role
Chief Strategy/Transf. Officer
Holding change
-4.5%
Trade date
Nov 3, 2026
3:58 PM ET 8-K
Other 8-K Filing Crestline Lending Solutions, LLC

Crestline Lending Solutions Other 8-K Filing

Crestline Lending Solutions, LLC entered into a Third Amended and Restated LLC Agreement to modify its governance structure. Key changes include redefining director removal 'for cause', lowering the voting threshold for director removal to 50%, and reducing the share forfeiture penalty for defaulting investors from 100% to 50%.

3:56 PM ET 8-K
Leadership Change Thunder Mountain Gold Inc THMG

Thunder Mountain Gold Leadership Change

Thunder Mountain Gold appointed mining industry veteran Ron Clayton to its Board of Directors, effective October 1, 2026. In connection with the appointment, Mr. Clayton was granted 400,000 stock options with an exercise price of $0.75 per share. Mr. Clayton brings over 40 years of experience, including previous roles as CEO of Tahoe Resources and Hecla Mining.

Counterparty
Ron Clayton
3:52 PM ET Form 4
Insider Selling Yum Brands Inc YUM

Yum Brands COO and CPO Tracy L. Skeans Sells $2.24M of Stock

Tracy L. Skeans, COO and CPO, sold 13,812 shares of Yum Brands Inc at $162.00 a share, worth $2.24M in total on Nov 4, 2026. Shares held after the trade: 3 (-100.0%).

Value
$2.24M
Shares
13,812
Price
$162.00
Role
COO and CPO
Holding change
-100.0%
Trade date
Nov 4, 2026
3:49 PM ET 10-Q
Financial Results Simmons First National Corp SFNC

Simmons First National Q3 2026 Results: Turns Profitable, Net Income $47.1M

For the nine months ended September 30, 2026, Simmons First National Corp reported net income of $182.3 million, a significant recovery from a net loss of $475.6 million in the prior year period which was impacted by a large loss on the sale of securities. Total assets decreased slightly to $24.1 billion, while net interest income improved to $601.8 million compared to $521.9 million in 2025.

Key figure
Net income $47.1M
3:49 PM ET 10-Q
Financial Results Red Rock Resorts, Inc. RRR

Red Rock Resorts Q3 2026 Results: Net Loss of $9.92M

Red Rock Resorts reported a net loss of $17.7 million for the third quarter of 2026, compared to a net income of $76.9 million in the prior year period, primarily due to significantly higher operating costs and expenses. Despite the quarterly loss, the company maintained a positive net income of $141.6 million for the nine months ended September 30, 2026, while total assets grew to $4.43 billion.

Key figure
Net loss $9.92M
3:46 PM ET 10-Q
Financial Results NB Bancorp, Inc. NBBK

NB Bancorp Q3 2026 Results: Net Income $23.1M, Up 50.6% YoY

NB Bancorp, Inc. reported a significant increase in net income to $23.1 million for the quarter ended September 30, 2026, compared to $15.4 million in the prior year period. This growth was driven by a 48% increase in net interest income, although the company also experienced higher noninterest expenses and a larger provision for credit losses.

Key figure
Net income $23.1M · +50.6% YoY
3:45 PM ET 8-K
Capital Raise Narragansett Bancorp, Inc. NARA

Narragansett Bancorp Capital Raise of $91M

Narragansett Bancorp, Inc. completed its initial public offering and two-tier holding company reorganization for BayCoast Bank on November 2, 2026. The company sold 9,098,800 shares of common stock at the adjusted maximum of its offering range, with shares beginning trade on the Nasdaq Capital Market under the symbol 'NARA'.

Value
$91M
3:44 PM ET Form 4
Insider Selling Yum Brands Inc YUM

Yum Brands KFC Division CEO Scott Mezvinsky Sells $43.7K of Stock

Scott Mezvinsky, KFC Division CEO, sold 273 shares of Yum Brands Inc at $160.00 a share, worth $43.7K in total on Nov 4, 2026. Shares held after the trade: 0 (-100.0%).

Value
$43.7K
Shares
273
Price
$160.00
Role
KFC Division CEO
Holding change
-100.0%
Trade date
Nov 4, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.